New York State Common Retirement Fund’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
2020
Q4
$348K Sell
2020
Q3
$160K Hold
2020
Q2
$234K Buy
2020
Q1
$111K Hold
2019
Q4
$144K Buy
2019
Q3
$10K Buy